{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:54:36Z","timestamp":1759564476371,"version":"3.41.0"},"reference-count":34,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.5551\/jat.65322","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T22:10:22Z","timestamp":1733263822000},"page":"688-702","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Significance of Early Computed Tomography Scan on Thrombus Regression Rate in Acute Pulmonary Embolism: Insights from the SAKURA PE\/DVT REGISTRY"],"prefix":"10.5551","volume":"32","author":[{"given":"Shohei","family":"Migita","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fukamachi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nihon University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Toyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nihon University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimie","family":"Ohkubo","sequence":"additional","affiliation":[{"name":"Itabashi Medical Association Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Tachibana","sequence":"additional","affiliation":[{"name":"Kawaguchi Municipal Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Oiwa","sequence":"additional","affiliation":[{"name":"Yokohama Chuo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haruta","sequence":"additional","affiliation":[{"name":"TMG Asaka Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumiki","family":"Nomoto","sequence":"additional","affiliation":[{"name":"Tokyo Rinkai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Arima","sequence":"additional","affiliation":[{"name":"Kasukabe Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Sekishindo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Tago","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Divisions of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI, and ISTH Steering Committee for World Thrombosis Day: Thrombosis: a major contributor to the global disease burden. J Thromb Haemost, 2014; 12: 1580-1590","DOI":"10.1111\/jth.12698"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) JCS Joint Working Group: Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J, 2011; 75: 1258-1281","DOI":"10.1253\/circj.CJ-88-0010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, and Weitz JI: Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol, 2014; 34: 2363-2371","DOI":"10.1161\/ATVBAHA.114.304488"},{"key":"4","unstructured":"4) Waheed SM, Kudaravalli P, and Hotwagner DT: Deep Vein Thrombosis. In: Deep Vein Thrombosis, StatPearls Publishing LLC, Treasure Island (FL), 2022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nakamura M, Yamada N, and Ito M: Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy. J Cardiol, 2015; 66: 451-459","DOI":"10.1016\/j.jjcc.2015.03.012"},{"key":"6","unstructured":"6) Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, and Schellong S: Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med, 2010; 363: 2499-2510"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) B\u00fcller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, and Segers A: Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med, 2012; 366: 1287-1297","DOI":"10.1056\/NEJMoa1113572"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, and Weitz JI: Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med, 2013; 369: 799-808","DOI":"10.1056\/NEJMoa1302507"},{"key":"9","unstructured":"9) B\u00fcller HR, D\u00e9cousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, and Wells P: Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med, 2013; 369: 1406-1415"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Takai S, Nakanishi N, Yokota I, Imai K, Yamada A, Kawasaki T, Kasahara T, Okada T, Sawada T, and Matoba S: Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients-a prospective interventional study. Sci Rep, 2022; 12: 21569","DOI":"10.1038\/s41598-022-26150-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ikeda S, Koga S, Yamagata Y, Eguchi M, Sato D, Muroya T, Yonekura T, Tsuneto A, Yoshimuta T, Koide Y, Kawano H, and Maemura K: Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer. J Cardiol, 2018; 72: 120-127","DOI":"10.1016\/j.jjcc.2018.03.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Schulman S, and Kearon C: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost, 2005; 3: 692-694","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ueno Y, Ikeda S, Motokawa T, Honda T, Kurobe M, Akashi R, Yonekura T, Yoshimuta T, Eguchi M, Kawano H, and Maemura K: Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism - A Single-Center Retrospective Study. Circ Rep, 2022; 4: 533-541","DOI":"10.1253\/circrep.CR-22-0095"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fukasawa T, Seki T, Nakashima M, and Kawakami K: Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study. J Thromb Haemost, 2022; 20: 2083-2097","DOI":"10.1111\/jth.15799"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, and Hirayama A: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J\u2019xactly Study). Circ J, 2020; 84: 1912-1921","DOI":"10.1253\/circj.CJ-20-0636"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yamada N, Mo M, Ohsawa A, Sato M, Umeyama M, Shima D, and Nakamura M: Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice - A Post-Marketing Surveillance. Circ J, 2021; 85: 2201-2207","DOI":"10.1253\/circj.CJ-20-0829"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakamura M, Yamada N, Asamura T, Shiosakai K, Uchino K: Safety and Effectiveness of Edoxaban in Japanese Venous Thromboembolism Patients - Final Analysis of One-Year Follow-up Data From a Japanese Postmarketing Observational Study (ETNA-VTE-Japan). Circ Rep, 2020; 2: 192-202","DOI":"10.1253\/circrep.CR-19-0127"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nakamura M, Miyata T, Ozeki Y, Takayama M, Komori K, Yamada N, Origasa H, Satokawa H, Maeda H, Tanabe N, Unno N, Shibuya T, Tanemoto K, Kondo K, and Kojima T: Current venous thromboembolism management and outcomes in Japan. Circ J, 2014; 78: 708-717","DOI":"10.1253\/circj.CJ-13-0886"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Konishi T, Akao M, Kobayashi Y, Inoue T, Oi M, Izumi T, Takahashi K, Tada T, Chen PM, Murata K, Tsuyuki Y, Sakai H, Saga S, Sasa T, Sakamoto J, Yamada C, Kinoshita M, Togi K, Ikeda T, Ishii K, Kaneda K, Mabuchi H, Otani H, Takabayashi K, Takahashi M, Shiomi H, Makiyama T, Ono K, and Kimura T: Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry. Circ J, 2018; 82: 1262-1270","DOI":"10.1253\/circj.CJ-17-1128"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Tamura T, Nakagawa Y, and Kimura T: Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry. Circ J, 2019; 83: 2271-2281","DOI":"10.1253\/circj.CJ-19-0515"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Agnelli G, Becattini C, Meyer G, Mu\u00f1oz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, and Verso M: Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med, 2020; 382: 1599-1607","DOI":"10.1056\/NEJMoa1915103"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, B\u00fcller HR, and Raskob GE: Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost, 2018; 118: 1439-1449","DOI":"10.1055\/s-0038-1667001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, and Levine M: Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). J Clin Oncol, 2018; 36: 2017-2023","DOI":"10.1200\/JCO.2018.78.8034"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Gali\u00e8 N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, and Zompatori M: 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014; 35: 3033-3069, 3069a-3069k","DOI":"10.5603\/KP.2014.0211"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, and Moores L: Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 2016; 149: 315-352","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, and Zierler BK: Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation, 2011; 123: 1788-1830","DOI":"10.1161\/CIR.0b013e318214914f"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, and Kimura T: Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial. Circulation, 2023; 148: 1665-1676","DOI":"10.1161\/CIRCULATIONAHA.123.066360"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nishimoto Y, Yamashita Y, Kim K, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, and Kimura T: Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry. Circ J, 2020; 84: 2006-2014","DOI":"10.1253\/circj.CJ-20-0223"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Fukamachi D, Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, and Hirayama A: Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J\u2019xactly. Curr Med Res Opin, 2022; 38: 1059-1068","DOI":"10.1080\/03007995.2022.2070379"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nakamura M, Fukuda I, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Okumura Y, and Hirayama A: Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly Study. Circ Rep, 2023; 5: 144-151","DOI":"10.1253\/circrep.CR-23-0008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) van Es J, Douma RA, Kamphuisen PW, Gerdes VE, Verhamme P, Wells PS, Bounameaux H, Lensing AW, and B\u00fcller HR: Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy. J Thromb Haemost, 2013; 11: 679-685","DOI":"10.1111\/jth.12150"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, Lensing AW, Kato M, Onuma J, Miyamoto Y, Iekushi K, and Kajikawa M: Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program. Thromb J, 2015; 13: 2","DOI":"10.1186\/s12959-015-0035-3"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, Villalta S, Dazzi F, and Girolami A: The risk of recurrent venous thromboembolism in patients with an Arg506--\uff1eGln mutation in the gene for factor V (factor V Leiden). N Engl J Med, 1997; 336: 399-403","DOI":"10.1056\/NEJM199702063360602"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Miyata T, Sato Y, Ishikawa J, Okada H, Takeshita S, Sakata T, Kokame K, Kimura R, Honda S, Kawasaki T, Suehisa E, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, and Ikeda Y: Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res, 2009; 124: 14-18","DOI":"10.1016\/j.thromres.2008.08.020"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/6\/32_65322\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:40:44Z","timestamp":1749271244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/6\/32_65322\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65322","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"65322"}}